MTEX
Mannatech, Incorporated NASDAQ$4.75
Mkt Cap $9.2M
52w Low $4.28
5.8% of range
52w High $12.45
50d MA $6.05
200d MA $7.95
P/E (TTM)
-0.6x
EV/EBITDA
-39.6x
P/B
—
Debt/Equity
-1.4x
ROE
291.3%
P/FCF
-3.6x
RSI (14)
—
ATR (14)
—
Beta
0.82
50d MA
$6.05
200d MA
$7.95
Avg Volume
9.2K
About
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flowe…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | AMC | — | -5.94 | — | 4.96 | +3.6% | +6.9% | +4.8% | +1.2% | -2.0% | -5.2% | — | — |
| Nov 12, 2025 | AMC | — | 1.01 | — | 9.51 | +0.0% | +0.1% | +0.8% | +0.0% | -1.8% | -0.5% | -9.0% | — |
| Aug 12, 2025 | AMC | — | -2.27 | — | 8.71 | -2.4% | +14.7% | +13.7% | +4.5% | -1.8% | -3.2% | -6.8% | — |
| May 13, 2025 | AMC | — | -0.80 | — | 11.79 | +0.0% | +0.0% | -7.6% | -10.5% | -23.6% | -23.6% | -18.9% | — |
| Mar 26, 2025 | AMC | — | 1.20 | — | 9.00 | +3.7% | +1.6% | -1.9% | +2.0% | -3.2% | -6.4% | +25.0% | — |
| Nov 12, 2024 | AMC | — | -0.17 | — | 7.50 | +0.1% | +6.7% | +0.1% | +12.5% | +8.4% | +7.3% | +57.1% | — |
| Aug 13, 2024 | AMC | — | -0.33 | — | 7.20 | +0.0% | -1.9% | +0.8% | +3.9% | -0.7% | -1.1% | +7.8% | — |
| May 14, 2024 | AMC | — | 0.63 | — | 7.40 | +10.1% | +7.4% | +3.5% | +3.5% | +3.5% | +3.5% | +7.8% | — |
| Mar 28, 2024 | AMC | — | -0.94 | — | — | — | — | — | — | — | — | — | — |
| Nov 7, 2023 | AMC | — | 0.01 | — | 8.78 | +0.0% | +0.0% | +0.0% | -3.3% | -3.3% | -3.6% | -4.3% | — |
Recent Filings
8-K
Mannatech Inc. -- 8-K Filing
Mannatech (MTEX) has 45 days to submit a Nasdaq compliance plan or faces delisting, with a potential 180-day extension if the plan is accepted by October 2026.
Apr 24
8-K
Unknown — 8-K Filing
MTEX's 8.2% Q4 revenue decline to $26.6 million signals weakening demand momentum, which could pressure earnings and warrant caution for investors concerned about sustained growth prospects.
Apr 15
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
Mannatech's late annual report filing signals potential financial or operational distress, which could trigger regulatory penalties, exchange delisting risk, and investor confidence loss if underlying issues aren't quickly resolved.
Apr 2
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Mannatech disclosed a late filing notification, signaling potential regulatory compliance issues or operational delays that could concern investors about management effectiveness and trigger NASDAQ listing requirement scrutiny.
Apr 2
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
Mannatech's late annual report filing signals potential financial or operational distress, risking delisting and eroding investor confidence in management's ability to maintain compliance and transparency.
Apr 1
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
MTEX experienced an executive change that could signal strategic shifts or instability; investors should monitor whether leadership changes improve operational execution or indicate internal governance concerns.
Mar 24
Data updated apr 26, 2026 1:40pm
· Source: massive.com